Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05120349
What this trial is testing

A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 390
Not applicableStudy completedNCT03116633
What this trial is testing

Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy

Who this might be right for
Non-Small Cell Lung Cancer
Inivata 34
Testing effectiveness (Phase 2)UnknownNCT00021008
What this trial is testing

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT05360225
What this trial is testing

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

Who this might be right for
Non Small Cell Lung Cancer
QIAGEN Gaithersburg, Inc 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT07155174
What this trial is testing

Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 180
Not applicableLooking for participantsNCT05378633
What this trial is testing

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Who this might be right for
Brain MetastasesNsclc
University Hospital Heidelberg 190
Testing effectiveness (Phase 2)Study completedNCT00043108
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00293085
What this trial is testing

An Open, Randomized, Multicentre, Phase II Pilot Study

Who this might be right for
Non-Small Cell Lung Cancer
Central European Cooperative Oncology Group 37
Not applicableLooking for participantsNCT07434518
What this trial is testing

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)Ended earlyNCT00290550
What this trial is testing

A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT00222404
What this trial is testing

Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University Hospital, Grenoble 556
Testing effectiveness (Phase 2)Study completedNCT00006004
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00217698
What this trial is testing

Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603791
What this trial is testing

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Shanghai Allink Biotherapeutics Co., Ltd. 252
Early research (Phase 1)Looking for participantsNCT06476808
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Who this might be right for
High-grade Serous Ovarian Carcinoma (HGSOC)Uterine Serous Carcinoma (USC)Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 240
Testing effectiveness (Phase 2)Study completedNCT00080938
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Eastern Cooperative Oncology Group 26
Large-scale testing (Phase 3)Looking for participantsNCT06646276
What this trial is testing

Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Bristol-Myers Squibb 530
Testing effectiveness (Phase 2)Study completedNCT00434668
What this trial is testing

Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Antwerp 99
Large-scale testing (Phase 3)UnknownNCT03083743
What this trial is testing

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Who this might be right for
Non-small-cell Lung Cancer (NSCLC) Stage IV
Shanghai Gebaide Biotechnology Co., Ltd. 417
Not applicableLooking for participantsNCT07079150
What this trial is testing

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Who this might be right for
Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University 1,500
Next Page